Trending stocks

CanaDream Corp reports 87.8% Net Income growth and 16.5% Revenue growth

10.07.2015 • About CanaDream Corp ($CDN) • By InTwits

CanaDream Corp reported FY2015 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • CanaDream Corp has high CAPEX intensity: 5 year average CAPEX/Revenue was 56.8%. At the same time it's a lot of higher than industry average of 8.2%.
  • CAPEX is quite volatile: 0.57 in 2015, 0.53 in 2014, 1.8 in 2013, 0.85 in 2012, 0.28 in 2011
  • The company has business model with low profitability: ROIC is at 7.5%
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.

CanaDream Corp ($CDN) key annual financial indicators

mln. CAD201120122013201420152015/2014
P&L
Revenue24.97526.49227.83629.27634.11116.5%
Gross Profit8.1378.9198.7609.38410.80015.1%
EBITDA6.0396.4706.3927.3067.4251.6%
Net Income0.3081.0930.6081.1332.12887.8%
Balance Sheet
Cash2.5783.0292.8833.7436.93885.4%
Short Term Debt17.46216.49014.92913.14215.22415.8%
Long Term Debt6.8287.0126.70813.40915.78117.7%
Cash flow
Capex17.14511.46310.59420.60021.6365.0%
Ratios
Revenue growth12.0%6.1%5.1%5.2%16.5%
EBITDA growth37.4%7.1%-1.2%14.3%1.6%
Gross Margin32.6%33.7%31.5%32.1%31.7%-0.4%
EBITDA Margin24.2%24.4%23.0%25.0%21.8%-3.2%
Net Income Margin1.2%4.1%2.2%3.9%6.2%2.4%
CAPEX, % of revenue68.6%43.3%38.1%70.4%63.4%-6.9%
ROIC10.5%7.2%5.8%7.8%7.5%-0.2%
ROE3.7%11.5%5.9%10.2%16.6%6.4%
Net Debt/EBITDA3.6x3.2x2.9x3.1x3.2x0.1x

Revenue and profitability


The company's Revenue jumped on 16.5% in FY2015. Revenue decline was accompanies by EBITDA margin decline. EBITDA Margin dropped on 14.5 pp from -6.9% to -21.4% in 2015.

Gross Margin showed almost no change in FY2015.

Net Income marign increased on 2.4 pp from 3.9% to 6.2% in FY2015.

Capital expenditures (CAPEX) and working capital investments


CanaDream Corp's CAPEX/Revenue was 63.4% in FY2015. CAPEX/Revenue jumped on 20.2 pp from 43.3% in FY2012 to 63.4% in FY2015. It's average CAPEX/Revenue for the last three years was 57.3%.The company has spent a lot to CAPEX (291% of EBITDA) to secure its growth.

Return on investment


The company operates at good ROE (16.59%) while ROIC is low (7.54%). ROIC showed almost no change in FY2015. ROE increased on 6.4 pp from 10.2% to 16.6% in FY2015.

Leverage (Debt)


Company's Net Debt / EBITDA is 3.2x and Debt / EBITDA is 4.2x. Net Debt / EBITDA jumped on 0.1x from 3.1x to 3.2x in FY2015. Debt surged on 16.8% in FY2015 while cash jumped on 85.4% in FY2015.

Appendix 1: Peers in Consumer, Non-cyclical


Below you can find CanaDream Corp benchmarking vs. other companies in Consumer, Non-cyclical industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.

Top companies by Revenue growth, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
GDI Integrated Facility Services Inc ($GDI)43.8%-38.8%-72.9%218,969.1%
Cardiome Pharma Corp ($COM)-97.7%-47.6%471.7%566.0%
Family Memorials Inc ($FAM)-13.6%54.7%22.9%245.3%
Nobilis Health Corp ($NHC)16.6%45.3%49.0%169.9%
Concordia Healthcare Corp ($CXR)159.5%
 
Median (85 companies)11.2%8.7%6.9%13.2%6.0%
CanaDream Corp ($CDN)6.1%5.1%5.2%16.5%


Top companies by Gross margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Nobilis Health Corp ($NHC)99.8%
Cipher Pharmaceuticals Inc ($CPH)99.5%98.3%
Heritage Global Inc ($HGP)99.5%95.7%
Ritchie Bros Auctioneers Inc ($RBA)87.9%88.7%88.4%88.0%
Concordia Healthcare Corp ($CXR)79.4%86.0%
 
Median (73 companies)35.4%37.4%36.1%35.6%28.1%
CanaDream Corp ($CDN)32.6%33.7%31.5%32.1%31.7%


Top companies by EBITDA margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Cipher Pharmaceuticals Inc ($CPH)-50.0%40.6%71.4%63.7%
Merus Labs International Inc ($MSL)32.9%64.7%46.2%
Valeant Pharmaceuticals International Inc ($VRX)37.0%30.6%27.8%45.6%
EnerCare Inc ($ECI)59.0%52.8%51.0%45.5%
Information Services Corp ($ISV)34.1%39.6%39.6%37.6%
 
Median (84 companies)7.9%7.9%8.3%10.5%7.7%
CanaDream Corp ($CDN)24.2%24.4%23.0%25.0%21.8%


Top companies by CAPEX/Revenue, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Neptune Technologies & Bioressources Inc ($NTB)6.0%4.7%73.6%84.6%119.0%
Ceapro Inc ($CZO)2.2%3.9%35.3%52.0%
Feronia Inc/Canada ($FRN)129.0%191.4%117.4%42.4%
Microbix Biosystems Inc ($MBX)1.0%1.2%3.0%40.3%
ProMetic Life Sciences Inc ($PLI)2.1%33.6%34.6%23.3%
 
Median (85 companies)2.3%2.6%2.4%2.4%3.0%
CanaDream Corp ($CDN)68.6%43.3%38.1%70.4%63.4%


Top companies by ROIC, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Biosyent Inc ($RX)45.5%71.7%62.4%62.9%
Information Services Corp ($ISV)56.0%71.8%72.8%58.9%
Covalon Technologies Ltd ($COV)-49.6%-75.8%-30.1%50.6%
Cipher Pharmaceuticals Inc ($CPH)-22.9%21.8%81.4%44.6%
Ceapro Inc ($CZO)69.9%-33.5%15.5%43.5%
 
Median (85 companies)7.4%6.7%6.7%6.9%8.4%
CanaDream Corp ($CDN)10.5%7.2%5.8%7.8%7.5%


Top companies by Net Debt / EBITDA

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Noble Iron Inc ($NIR)25.5x12.9x227.3x
Family Memorials Inc ($FAM)15.2x
Amica Mature Lifestyles Inc ($ACC)11.7x9.4x14.7x13.8x
Cott Corp ($BCB)2.6x2.0x2.2x13.4x
CRH Medical Corp ($CRH)-2.3x-3.1x-3.5x12.0x
 
Median (69 companies)1.8x2.5x2.1x2.7x1.6x
CanaDream Corp ($CDN)3.6x3.2x2.9x3.1x3.2x